DNAX Immunologists Work To Balance Industry, Academia

The fence between industry and academia seems like a precarious place to sit. But a team of California scientists makes the balancing act look easy. Their perch on that fence has been the perfect place for cranking out highly cited research, including four “Hot Papers” identified by The Scientist in the past year (May I, 1989, page 12). The laboratories of immunologists Robert Coffman and Tim Mosmann are side by side on the secondfloor of DNAX Research Institute in Palo Alto. Se

Written byLaurel Joyce
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The fence between industry and academia seems like a precarious place to sit. But a team of California scientists makes the balancing act look easy. Their perch on that fence has been the perfect place for cranking out highly cited research, including four “Hot Papers” identified by The Scientist in the past year (May I, 1989, page 12).

The laboratories of immunologists Robert Coffman and Tim Mosmann are side by side on the secondfloor of DNAX Research Institute in Palo Alto. Seven years ago, in the early days of the company, Coffman and Mosmann were assigned to neighboring labs by chance, and they immediately began developing a formula for a practical combination of academic and industrial science that has been working for them ever since. And even after subsequent moves, they have continued to work side by side.

DNAX (pronounced “Deen-x”) was designed as a hybrid biomedical research company from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies